Free Trial
NASDAQ:BCTXW

BriaCell Therapeutics (BCTXW) Stock Price, News & Analysis

BriaCell Therapeutics logo
$0.15 0.00 (0.00%)
As of 01/17/2025

About BriaCell Therapeutics Stock (NASDAQ:BCTXW)

Key Stats

Today's Range
$0.15
$0.15
50-Day Range
$0.14
$0.54
52-Week Range
$0.11
$2.30
Volume
210 shs
Average Volume
111,150 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Receive BCTXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCTXW Stock News Headlines

This Crypto Is Set to Explode in January
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
BriaCell Therapeutics Faces Uncertain Financial Future
See More Headlines

BCTXW Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at $0.2895 at the beginning of 2025. Since then, BCTXW shares have decreased by 48.6% and is now trading at $0.1489.
View the best growth stocks for 2025 here
.

Shares of BCTXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BCTXW
Web
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NASDAQ:BCTXW) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners